Hypereosinophilic SyndromeSymptoms, Doctors, Treatments, Advances & More
Learn About Hypereosinophilic Syndrome
- Hypereosinophilic syndrome
- HES
- Hypereosinophilic syndrome, idiopathic
University Of Utah Hospital Dermatology Department
Gerald Gleich is an Allergy and Immunologist practicing medicine in Salt Lake City, Utah. Dr. Gleich is rated as an Elite provider by MediFind in the treatment of Hypereosinophilic Syndrome. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Hypereosinophilic Syndrome, Eosinophilic Esophagitis, Eosinophilic Asthma, Acute Eosinophilic Pneumonia, and Endoscopy. Dr. Gleich is board certified in American Board Of Internal Medicine. Dr. Gleich is currently accepting new patients.
National Jewish Health
Michael Wechsler is a Pulmonary Medicine provider practicing medicine in Denver, Colorado. Dr. Wechsler is rated as an Elite provider by MediFind in the treatment of Hypereosinophilic Syndrome. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Asthma, Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Hypereosinophilic Syndrome, Eosinophilic Asthma, and Endoscopy. Dr. Wechsler is board certified in American Board Of Internal Medicine. Dr. Wechsler is currently accepting new patients.
Domino's Farms
Anna Kovalszki is a primary care provider, practicing in Internal Medicine in Ann Arbor, Michigan. Dr. Kovalszki is rated as an Elite provider by MediFind in the treatment of Hypereosinophilic Syndrome. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Hypereosinophilic Syndrome, Anaphylaxis, Sinusitis, and Allergic Rhinitis. Dr. Kovalszki is currently accepting new patients.
Summary: This is a 52-week, randomized, placebo-controlled, double-blind, parallel group, multicenter study of depemokimab in adults with uncontrolled HES receiving standard of care (SoC) therapy. The study will recruit patients with a confirmed diagnosis of HES and who are on stable HES therapy for at least 4 weeks prior to randomization (Visit 2). Eligible participants must have uncontrolled HES with a h...
Summary: Eosinophils are a type of white blood cell. Elevated eosinophil levels can damage the heart, nerves, and other organs, in the syndrome known as hypereosinophilic syndrome (HES). Some individuals have a hereditary form of HES known as familial eosinophilia (FE). More research on the causation and mechanisms of HES is needed in order to design more effective and less toxic therapies. This study will...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center